Qiryat Shemona, Israel
Qiryat Shemona, Israel

Time filter

Source Type

Fedorenko V.,Ivan Franko National University of Lviv | Genilloud O.,Fundacion MEDINA | Horbal L.,Ivan Franko National University of Lviv | Marcone G.L.,University of Insubria | And 6 more authors.
BioMed Research International | Year: 2015

Concern over the reports of antibiotic-resistant bacterial infections in hospitals and in the community has been publicized in the media, accompanied by comments on the risk that we may soon run out of antibiotics as a way to control infectious disease. Infections caused by Enterococcus faecium, Staphylococcus aureus, Klebsiella species, Clostridium difficile, Acinetobacter baumannii, Pseudomonas aeruginosa, Escherichia coli, and other Enterobacteriaceae species represent a major public health burden. Despite the pharmaceutical sector's lack of interest in the topic in the last decade, microbial natural products continue to represent one of the most interesting sources for discovering and developing novel antibacterials. Research in microbial natural product screening and development is currently benefiting from progress that has been made in other related fields (microbial ecology, analytical chemistry, genomics, molecular biology, and synthetic biology). In this paper, we review how novel and classical approaches can be integrated in the current processes for microbial product screening, fermentation, and strain improvement. © 2015 Victor Fedorenko et al.

Loading Galilee Research Institute MIGAL collaborators
Loading Galilee Research Institute MIGAL collaborators